Log in to save to my catalogue

Diosgenin Exerts Antitumor Activity via Downregulation of Skp2 in Breast Cancer Cells

Diosgenin Exerts Antitumor Activity via Downregulation of Skp2 in Breast Cancer Cells

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7317312

Diosgenin Exerts Antitumor Activity via Downregulation of Skp2 in Breast Cancer Cells

About this item

Full title

Diosgenin Exerts Antitumor Activity via Downregulation of Skp2 in Breast Cancer Cells

Publisher

United States: Hindawi

Journal title

BioMed research international, 2020, Vol.2020 (1), p.8072639

Language

English

Formats

Publication information

Publisher

United States: Hindawi

More information

Scope and Contents

Contents

Background. Breast cancer is the common malignancy with high morbidity and mortality in women. S-phase kinase-associated protein 2 (Skp2) has been characterized to play an oncogenic role in the breast carcinogenesis and progression. Therefore, inactivation of Skp2 in breast cancer might be a novel approach for fighting breast malignancy. A natural...

Alternative Titles

Full title

Diosgenin Exerts Antitumor Activity via Downregulation of Skp2 in Breast Cancer Cells

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7317312

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7317312

Other Identifiers

ISSN

2314-6133

E-ISSN

2314-6141

DOI

10.1155/2020/8072639

How to access this item